Literature DB >> 17089047

Distribution of Tankyrase-1 mRNA expression in colon cancer and its prospective correlation with progression stage.

Stefania Gelmini1, Melissa Poggesi, Pamela Pinzani, Sara Ciullini Mannurita, Fabio Cianchi, Rosa Valanzano, Claudio Orlando.   

Abstract

We tested Tankyrase-1 mRNA expression in colon cancer patients to evaluate the prognostic role of this parameter by real-time RT-PCR in a retrospective group of 82 unselected patients with colon cancer. Paired cancer and corresponding not affected tissues were used. Laser-assisted microdissection was used to measure Tankyrase-1 mRNA in homogeneous cancer cell populations and in normal colon epithelium of the same patients. Tankyrase-1 mRNA in colon cancers, as a mean, was significantly higher than in paired not affected tissues (p<0.0001), but its level correlates inversely with a cancer progression stage. Survival analysis indicated that lower Tankyrase-1 mRNA expression in colon cancers was significantly associated to reduced patient survival (p=0.019) and disease-free interval (p=0.035), confirmed also in a multi-variate analysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17089047

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

1.  Genetic variation in telomere maintenance genes in relation to ovarian cancer survival.

Authors:  Holly R Harris; Immaculata De Vivo; Linda J Titus; Allison F Vitonis; Jason Y Y Wong; Daniel W Cramer; Kathryn L Terry
Journal:  Int J Mol Epidemiol Genet       Date:  2012-08-31

2.  Expression of tankyrase 1 in gastric cancer and its correlation with telomerase activity.

Authors:  Jinbo Gao; Jinghui Zhang; Yaoping Long; Yuan Tian; Xiaoming Lu
Journal:  Pathol Oncol Res       Date:  2011-04-01       Impact factor: 3.201

3.  Unravelling the Mechanistic Role of Quinazolinone Pharmacophore in the Inhibitory Activity of Bis-quinazolinone Derivative on Tankyrase-1 in the Treatment of Colorectal Cancer (CRC) and Non-small Cell Lung Cancer (NSCLC): A Computational Approach.

Authors:  Felix O Okunlola; Oluwole B Akawa; Temitayo I Subair; Kehinde F Omolabi; Mahmoud E S Soliman
Journal:  Cell Biochem Biophys       Date:  2021-08-28       Impact factor: 2.194

4.  Gene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.

Authors:  Masahiro Kato; Masahiro Nakayama; Minako Agata; Kenichi Yoshida
Journal:  Tumour Biol       Date:  2012-12-18

5.  Inhibitory effects of XAV939 on the proliferation of small-cell lung cancer H446 cells and Wnt/β-catenin signaling pathway in vitro.

Authors:  Fei Pan; Fangzhen Shen; Lijun Yang; Lijian Zhang; Wenxuan Guo; Jinxin Tian
Journal:  Oncol Lett       Date:  2018-05-24       Impact factor: 2.967

6.  Intracellular distribution of Tankyrases as detected by multicolor immunofluorescence techniques.

Authors:  M G Bottone; G Santin; C Soldani; P Veneroni; A I Scovassi; C Alpini
Journal:  Eur J Histochem       Date:  2012-01-20       Impact factor: 3.188

7.  Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling.

Authors:  Laura Mariotti; Catherine M Templeton; Michael Ranes; Patricia Paracuellos; Nora Cronin; Fabienne Beuron; Edward Morris; Sebastian Guettler
Journal:  Mol Cell       Date:  2016-08-04       Impact factor: 17.970

8.  XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway.

Authors:  Xiao-Hong Tian; Wei-Jian Hou; Yan Fang; Jun Fan; Hao Tong; Shu-Ling Bai; Qu Chen; He Xu; Yan Li
Journal:  J Exp Clin Cancer Res       Date:  2013-12-05

Review 9.  Tankyrases: structure, function and therapeutic implications in cancer.

Authors:  Teemu Haikarainen; Stefan Krauss; Lari Lehtio
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

10.  The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the β-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt.

Authors:  Sushil C Regmi; Su Young Park; Seung Joo Kim; Suhrid Banskota; Sajita Shah; Dong-Hee Kim; Jung-Ae Kim
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.